암닐 파마슈티컬스(Amneal Pharmaceuticals, Inc.)
US ˙ NasdaqGS ˙ US03168L1052

SecurityAMRX / Amneal Pharmaceuticals, Inc.
InstitutionGroup One Trading, L.p.
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Group One Trading, L.p. ownership in AMRX / Amneal Pharmaceuticals, Inc.

On November 12, 2025 - Group One Trading, L.p. filed a 13F-HR form disclosing ownership of 0 shares of Amneal Pharmaceuticals, Inc. (US:AMRX) valued at $0 USD as of September 30, 2025. The entity filed a previous 13F-HR on August 14, 2025 disclosing 2,991 shares of Amneal Pharmaceuticals, Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Group One Trading, L.p. has a history of taking positions in derivatives of the underlying security (AMRX) in the form of stock options. The firm currently holds call options representing 73,900 of underlying shares valued at $931,140 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

AMRX / Amneal Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-11-12 2025-09-30 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 0 -2,991 -100.00 0 -100.00
2025-08-14 2025-06-30 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 2,991 -202 -6.33 24 -7.69 0.0001
2025-05-14 2025-03-31 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 3,193 2,494 356.80 27 420.00 0.0001
2025-05-14 2024-12-31 13F/A-1 AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 699 699 6 0.0000
2025-02-14 2024-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 699 699 6 0.0000
2023-11-09 2023-09-30 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 0 -880 -100.00 0 -100.00
2023-08-09 2023-06-30 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 880 880 3 0.0000
2023-05-12 2023-03-31 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 0 -35,532 -100.00 0 -100.00
2023-02-09 2022-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 35,532 -385,477 -91.56 71 -91.76 0.0002
2022-11-09 2022-09-30 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 421,009 -71,279 -14.48 850 -45.69 0.0017
2022-08-11 2022-06-30 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 492,288 372,128 309.69 1,565 212.38 0.0025
2022-05-12 2022-03-31 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 120,160 6,306 5.54 501 -8.07 0.0005
2022-02-11 2021-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 113,854 78,102 218.45 545 185.34 0.0004
2021-11-12 2021-09-30 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 35,752 11,713 48.72 191 55.28 0.0002
2021-08-10 2021-06-30 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 24,039 -1,095 -4.36 123 -27.22 0.0001
2021-05-12 2021-03-31 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 25,134 25,134 169 0.0003
2021-02-10 2020-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 0 -3,836 -100.00 0 -100.00
2020-11-12 2020-09-30 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 3,836 3,836 15 0.0000
2020-08-13 2020-06-30 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 0 -41,133 -100.00 0 -100.00
2020-05-13 2020-03-31 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 41,133 -18,855 -31.43 143 -50.52 0.0012
2020-02-10 2019-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 59,988 21,237 54.80 289 158.04 0.0020
2019-11-12 2019-09-30 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 38,751 37,300 2,570.64 112 1,020.00 0.0009
2019-08-09 2019-06-30 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 1,451 1,451 10 0.0001
2019-02-05 2018-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 0 -34,090 -100.00 0 -100.00
2018-11-08 2018-09-30 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 34,090 -17,600 -34.05 756 -10.85 0.0060
2018-08-13 2018-06-30 13F AMNEAL PHARMACEUTICALS COM STK CL A 03168L105 51,690 51,690 848 0.0073
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-11 2025-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 73,900 -19.41 931 1.53 n/a n/a n/a
2025-11-12 2025-09-30 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 91,700 1,004.82 918 1,268.66 n/a n/a n/a
2025-08-14 2025-06-30 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 8,300 -83.91 67 -84.49 n/a n/a n/a
2025-05-14 2025-03-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 51,600 142.25 432 157.14 n/a n/a n/a
2025-05-14 2024-12-31 13F/A AMNEAL PHARMACEUTICALS COM STK CL A Call 21,300 37.42 169 31.25 n/a n/a n/a
2025-02-14 2024-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 21,300 169 n/a n/a n/a
2024-11-14 2024-09-30 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 15,500 74.16 129 128.57 n/a n/a n/a
2024-08-14 2024-06-30 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 8,900 -95.57 57 -95.40 n/a n/a n/a
2024-05-10 2024-03-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 201,000 -10.90 1,218 -11.03 n/a n/a n/a
2024-02-14 2023-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 225,600 374.95 1,369 584.50 n/a n/a n/a
2023-11-09 2023-09-30 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 47,500 559.72 200 809.09 n/a n/a n/a
2023-08-09 2023-06-30 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 7,200 22 n/a n/a n/a
2023-05-12 2023-03-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-09 2022-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 1,100 0.00 2 0.00 n/a n/a n/a
2022-11-09 2022-09-30 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 1,100 -94.30 2 -96.72 n/a n/a n/a
2022-08-11 2022-06-30 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 19,300 -7.66 61 -29.89 n/a n/a n/a
2022-05-12 2022-03-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 20,900 -44.71 87 -51.93 n/a n/a n/a
2022-02-11 2021-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 37,800 177.94 181 147.95 n/a n/a n/a
2021-11-12 2021-09-30 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 13,600 -64.21 73 -62.56 n/a n/a n/a
2021-08-10 2021-06-30 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 38,000 -0.52 195 -24.12 n/a n/a n/a
2021-05-12 2021-03-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 38,200 -51.09 257 -28.01 n/a n/a n/a
2021-02-10 2020-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 78,100 357 n/a n/a n/a
2020-11-12 2020-09-30 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-08-13 2020-06-30 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 13,200 169.39 63 270.59 n/a n/a n/a
2020-05-13 2020-03-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 4,900 -57.76 17 -69.64 n/a n/a n/a
2020-02-10 2019-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 11,600 364.00 56 700.00 n/a n/a n/a
2019-11-12 2019-09-30 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 2,500 -79.17 7 -91.86 n/a n/a n/a
2019-08-09 2019-06-30 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 12,000 -41.18 86 -70.24 n/a n/a n/a
2019-05-14 2019-03-31 13F/A AMNEAL PHARMACEUTICALS COM STK CL A Call 20,400 289 n/a n/a n/a
2019-05-13 2019-03-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 20,400 289 n/a n/a n/a
2019-02-05 2018-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 0 -100.00 0 -100.00 n/a n/a n/a
2018-11-08 2018-09-30 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 19,300 2.12 428 38.06 n/a n/a n/a
2018-08-13 2018-06-30 13F AMNEAL PHARMACEUTICALS COM STK CL A Call 18,900 310 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-12 2025-09-30 13F AMNEAL PHARMACEUTICALS COM STK CL A Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-08-14 2025-06-30 13F AMNEAL PHARMACEUTICALS COM STK CL A Put 900 -95.57 7 -95.88 n/a n/a n/a
2025-05-14 2025-03-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Put 20,300 125.56 170 139.44 n/a n/a n/a
2025-05-14 2024-12-31 13F/A AMNEAL PHARMACEUTICALS COM STK CL A Put 9,000 0.00 71 -4.05 n/a n/a n/a
2025-02-14 2024-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Put 9,000 71 n/a n/a n/a
2024-11-14 2024-09-30 13F AMNEAL PHARMACEUTICALS COM STK CL A Put 9,000 75 n/a n/a n/a
2023-05-12 2023-03-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-02-09 2022-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Put 38,300 -91.45 76 -91.60 n/a n/a n/a
2022-11-09 2022-09-30 13F AMNEAL PHARMACEUTICALS COM STK CL A Put 448,200 -32.88 905 -57.39 n/a n/a n/a
2022-08-11 2022-06-30 13F AMNEAL PHARMACEUTICALS COM STK CL A Put 667,800 122.45 2,124 69.65 n/a n/a n/a
2022-05-12 2022-03-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Put 300,200 0.07 1,252 -12.87 n/a n/a n/a
2022-02-11 2021-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Put 300,000 986.96 1,437 877.55 n/a n/a n/a
2021-11-12 2021-09-30 13F AMNEAL PHARMACEUTICALS COM STK CL A Put 27,600 463.27 147 488.00 n/a n/a n/a
2021-08-10 2021-06-30 13F AMNEAL PHARMACEUTICALS COM STK CL A Put 4,900 -94.74 25 -96.01 n/a n/a n/a
2021-05-12 2021-03-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Put 93,200 4,560.00 627 6,866.67 n/a n/a n/a
2021-02-10 2020-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Put 2,000 9 n/a n/a n/a
2020-08-13 2020-06-30 13F AMNEAL PHARMACEUTICALS COM STK CL A Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-13 2020-03-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Put 18,100 -66.36 63 -75.68 n/a n/a n/a
2020-02-10 2019-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Put 53,800 -36.93 259 4.86 n/a n/a n/a
2019-11-12 2019-09-30 13F AMNEAL PHARMACEUTICALS COM STK CL A Put 85,300 1,450.91 247 533.33 n/a n/a n/a
2019-08-09 2019-06-30 13F AMNEAL PHARMACEUTICALS COM STK CL A Put 5,500 5,400.00 39 3,800.00 n/a n/a n/a
2019-05-14 2019-03-31 13F/A AMNEAL PHARMACEUTICALS COM STK CL A Put 100 1 n/a n/a n/a
2019-05-13 2019-03-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Put 100 1 n/a n/a n/a
2019-02-05 2018-12-31 13F AMNEAL PHARMACEUTICALS COM STK CL A Put 0 -100.00 0 -100.00 n/a n/a n/a
2018-11-08 2018-09-30 13F AMNEAL PHARMACEUTICALS COM STK CL A Put 33,700 0.00 748 35.26 n/a n/a n/a
2018-08-13 2018-06-30 13F AMNEAL PHARMACEUTICALS COM STK CL A Put 33,700 553 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.